EU politicos press for April regulation on clinical data disclosure
This article was originally published in Scrip
Executive Summary
The continuing currency and economic crisis in Europe, spiced this week by the panic in Cyprus’s banking system, has not deflected European politicians from the much more urgent business of trying to loosen pharma’s hold on clinical data. In the European Parliament, MEPs backed calls for trial data to be published when a new drug has been approved for marketing. While most of the vocal members favored data publication, opinions differed as to how much data should be released, at what point and in what manner.